Entries will be evaluated on 4 criteria:
This prestigious award recognises pharma brand teams who have successfully changed their strategic and operational approach due to the global COVID-19 pandemic to continue to supply, support and engage with healthcare professionals and patients. We welcome entries across different therapy areas and organisations who have faced a changing environment and demonstrated agility, innovation and speed to adapt their brand/service offering and operational model.
Successful entries will need to show clearly how they worked collaboratively both internally and with external stakeholders to understand the challenges faced and how they approached these, displaying practicality, flexibility and kindness in the way they approached their challenges.
Entries will be considered for activities between January and July 2020.
Download specific entry submission document for this category.
Entry Format
A special abbreviated entry form has been designed for this award and a gold, silver and bronze will be awarded to the top 3 entries.
Entry deadline | 27 August 2020 |
Extended entry deadline | 3 September 2020* *additional fee applies |
Judging Day | 1 October 2020 |
Company of the Year Interviews | 22 October 2020 |
PMEA Event | 25 November 2020 |